Cubist Systematic Strategies, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$117,000
-29.5%
35,935
-26.8%
0.00%
-77.8%
Q3 2017$166,000
+124.3%
49,062
+64.0%
0.01%
+80.0%
Q2 2017$74,000
+89.7%
29,918
+73.4%
0.01%
+66.7%
Q1 2017$39,000
-65.2%
17,253
-67.5%
0.00%
-66.7%
Q4 2016$112,000
+34.9%
53,051
+114.2%
0.01%
+80.0%
Q3 2016$83,000
-17.8%
24,771
-23.3%
0.01%
-16.7%
Q2 2016$101,000
+34.7%
32,310
+43.5%
0.01%
+50.0%
Q1 2016$75,000
-9.6%
22,516
-4.0%
0.00%
-20.0%
Q4 2015$83,000
-22.4%
23,445
+10.5%
0.01%0.0%
Q3 2015$107,00021,2120.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders